Behind Vaccine Stock Moderna’s Bearish Rating
Moderna stock rating: The COVID-19 vaccine maker’s stock has skyrocketed in the past year — but it scores a “bearish” rating. Here’s why.
Posted by Charles Sizemore | Mar 23, 2021 | Investing
Moderna stock rating: The COVID-19 vaccine maker’s stock has skyrocketed in the past year — but it scores a “bearish” rating. Here’s why.
Posted by Charles Sizemore | Mar 20, 2021 | Investing
In case you missed it, the Federal Reserve made waves this past week. That raises the question: Is it time to buy bitcoin or gold?
Posted by Charles Sizemore | Mar 19, 2021 | Investing
As the U.S. government attempts to lift the nation’s economy out of a recession, infrastructure spending and construction are set to spike. Commodity companies like aluminum manufacturer Norsk Hydro (OTC: NHYDY) are primed for gains in the next few years.
Posted by Charles Sizemore | Mar 18, 2021 | Personal Finance
Sometimes when investing, it’s best to keep it simple. That’s why we employ certain systems and try our best to avoid easy mistakes.
Posted by Charles Sizemore | Mar 17, 2021 | Investing
Kinder Morgan Inc. (NYSE: KMI) has had it rough, but it’s worked to become a more solid investment for your dividend portfolio in 2021.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below